{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:12596"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:12596","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Exploring the management of patients with chronic limb threatening ischaemia due to infra-popliteal disease","abstract":"Introduction The incidence of chronic limb threatening ischaemia (CLTI) secondary to infra-popliteal (IP) disease is increasing. Despite this, the current evidence base supporting clinical management decisions is poor. Methods & Aims To use the vehicle of the Bypass versus Angioplasty in Severe Ischaemia of the Leg 1 and 2 (BASIL-1 and 2) randomised controlled trials to provide new evidence to help inform treatment decisions for patients presenting with CLTI secondary to IP disease. Results Both the IP subgroup analysis of BASIL-1 and retrospective analyses of data from our own institution revealed that vein bypass was associated improved overall survival, although patients experienced higher rates of morbidity and longer in hospital stays than those undergoing endovascular treatment. Although immediate technical outcomes have improved in endovascular treatment since BASIL-1, overall survival and limb salvage have not. IP vein bypass and major amputation are more expensive in terms of human resources and in-patient costs. The overall survival of patients with untreated CLTI is poor at around 50% at 1 year. Conclusions Evidence from this thesis suggests that IP endovascular treatment should likely be reserved for those who are not suitable for vein bypass, however further randomised trials and a large, concerted, public health effort are required to confirm this and achieve improved outcomes in this challenging patient group.","abstract_html":"Introduction The incidence of chronic limb threatening ischaemia (CLTI) secondary to infra-popliteal (IP) disease is increasing. Despite this, the current evidence base supporting clinical management decisions is poor. Methods &amp; Aims To use the vehicle of the Bypass versus Angioplasty in Severe Ischaemia of the Leg 1 and 2 (BASIL-1 and 2) randomised controlled trials to provide new evidence to help inform treatment decisions for patients presenting with CLTI secondary to IP disease. Results Both the IP subgroup analysis of BASIL-1 and retrospective analyses of data from our own institution revealed that vein bypass was associated improved overall survival, although patients experienced higher rates of morbidity and longer in hospital stays than those undergoing endovascular treatment. Although immediate technical outcomes have improved in endovascular treatment since BASIL-1, overall survival and limb salvage have not. IP vein bypass and major amputation are more expensive in terms of human resources and in-patient costs. The overall survival of patients with untreated CLTI is poor at around 50% at 1 year. Conclusions Evidence from this thesis suggests that IP endovascular treatment should likely be reserved for those who are not suitable for vein bypass, however further randomised trials and a large, concerted, public health effort are required to confirm this and achieve improved outcomes in this challenging patient group.","abstract_has_math":false,"creators":["Popplewell, Matthew Adam"],"institution":"University of Birmingham","degree_name":"d_m_d","degree_level":"d_m_d","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022-07","date_published":"2022-07","updated_at":"2026-11-19T09:31:48Z","subjects":["RD Surgery"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/12596/13/Popplewell2022MD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A12596","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Popplewell, Matthew Adam"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2022-07-14"]},{"key":"dc:date.issued","label":"Date","values":["2022-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Cardiovascular Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/12596/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_m_d"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_m_d"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RD Surgery"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/12596/13/Popplewell2022MD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Introduction The incidence of chronic limb threatening ischaemia (CLTI) secondary to infra-popliteal (IP) disease is increasing. Despite this, the current evidence base supporting clinical management decisions is poor. Methods & Aims To use the vehicle of the Bypass versus Angioplasty in Severe Ischaemia of the Leg 1 and 2 (BASIL-1 and 2) randomised controlled trials to provide new evidence to help inform treatment decisions for patients presenting with CLTI secondary to IP disease. Results Both the IP subgroup analysis of BASIL-1 and retrospective analyses of data from our own institution revealed that vein bypass was associated improved overall survival, although patients experienced higher rates of morbidity and longer in hospital stays than those undergoing endovascular treatment. Although immediate technical outcomes have improved in endovascular treatment since BASIL-1, overall survival and limb salvage have not. IP vein bypass and major amputation are more expensive in terms of human resources and in-patient costs. The overall survival of patients with untreated CLTI is poor at around 50% at 1 year. Conclusions Evidence from this thesis suggests that IP endovascular treatment should likely be reserved for those who are not suitable for vein bypass, however further randomised trials and a large, concerted, public health effort are required to confirm this and achieve improved outcomes in this challenging patient group."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Exploring the management of patients with chronic limb threatening ischaemia due to infra-popliteal disease"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Popplewell, Matthew Adam"],"dc:date":["2022-07-14"],"dc:date.issued":["2022-07"],"dc:description.abstract":["Introduction The incidence of chronic limb threatening ischaemia (CLTI) secondary to infra-popliteal (IP) disease is increasing. Despite this, the current evidence base supporting clinical management decisions is poor. Methods & Aims To use the vehicle of the Bypass versus Angioplasty in Severe Ischaemia of the Leg 1 and 2 (BASIL-1 and 2) randomised controlled trials to provide new evidence to help inform treatment decisions for patients presenting with CLTI secondary to IP disease. Results Both the IP subgroup analysis of BASIL-1 and retrospective analyses of data from our own institution revealed that vein bypass was associated improved overall survival, although patients experienced higher rates of morbidity and longer in hospital stays than those undergoing endovascular treatment. Although immediate technical outcomes have improved in endovascular treatment since BASIL-1, overall survival and limb salvage have not. IP vein bypass and major amputation are more expensive in terms of human resources and in-patient costs. The overall survival of patients with untreated CLTI is poor at around 50% at 1 year. Conclusions Evidence from this thesis suggests that IP endovascular treatment should likely be reserved for those who are not suitable for vein bypass, however further randomised trials and a large, concerted, public health effort are required to confirm this and achieve improved outcomes in this challenging patient group."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/12596/13/Popplewell2022MD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Cardiovascular Sciences"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/12596/"],"dc:subject":["RD Surgery"],"dcterms:accessrights":["public"],"dc:title":["Exploring the management of patients with chronic limb threatening ischaemia due to infra-popliteal disease"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_m_d"],"dc:type.qualificationname":["d_m_d"]},"updated_at":"2026-11-19T09:31:48Z"}